Back
VYS
Vysarn Limited
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 116.47%
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
7
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Vysarn Ltd. engages in the hydrogeological drilling, test pumping, and water consultancy businesses. The firm is engaged in hydrogeological drilling, test pumping, reinjection water services and water consultancy businesses predominately in Western Australia. Its segments include Industrial, Technologies, and Advisory. Its Industrial segment consisting of Pentium Hydro (PH) and Pentium Test Pumping (PTP). The Advisory segment consisting of Pentium Water (PW). The Technology segment consisting of Project Engineering (ProEng). The Company, through Waste Water Services Pty Ltd., is engaged in the design, manufacture, installation, and maintenance of waste water treatment plants, potable water treatment plants, and pumping stations. The Company’s subsidiaries include Pentium Hydro Pty Ltd, Pentium Test Pumping Pty Ltd, Pentium Water Pty Ltd, Project Engineering (WA) Pty Ltd, Vysarn Asset Management Pty Ltd, and CMP Consulting Group Pty Ltd.
📈 Performance
Price History
+5886.17%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.58
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in VYS
7
📊 Total Capital Earnings
$28K
🔃 Average investment frequency
15 weeks
💵 Average investment amount
$3,117
⏰ Last time a customer invested in VYS
6 days
VYS investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
20%
50k - 100k
Less than 50k
70%
👶 Age of investors
18 - 25
14%
26 - 34
35 - 90
86%
🙋 Legal gender of investors
Female
14%
Male
86%
Pearlers who invest in VYS also invest in...
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
23.64%
📊 Share price
$67.71 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
10.02%
📊 Share price
$111.05 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
🧱 MATERIALS
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
Telix Pharmaceuticals Limited.engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-15. The company is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.
🙌 Performance (5Yr p.a)
165.30%
📊 Share price
$15.38 AUD
🧬 BIOTECHNOLOGY
Pilbara Minerals Ltd. engages in the provision of exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 877 full-time employees. The company went IPO on 2007-09-19. The firm owns 100% of an independent hard-rock lithium operation, the Pilgangoora operation in Australia, and the Colina Project in Brazil. Its Pilgangoora operation is located 140 kilometers (kms) from Port Hedland in Western Australia’s resource rich Pilbara region on Nyamal and Kariyarra Country. Spodumene concentrate from its Pilgangoora operation is shipped from Port Hedland, the bulk export port, to lithium chemical converters primarily in China. The firm's Colina project is located 10 kms from the town of Salinas in the world class mining jurisdiction of Minas Gerais, Brazil. The firm is also integrated into the lithium value chain through its joint venture with POSCO in South Korea, which manufactures battery-grade lithium hydroxide.
🙌 Performance (5Yr p.a)
146.38%
📊 Share price
$2.48 AUD
🕊️ SOCIALLY AWARE
⛏️ MINING
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
🙌 Performance (5Yr p.a)
21.98%
📊 Share price
$55.33 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
🤖 TECHNOLOGY
Want more shares? Try these...
